IL6 and acute myeloid leukemia: Leukemic stem cells and blasts isolated from AML patients release elevated levels of IL-1β and IL-6 in vitro, generating a supportive feedback loop able to maintain the proliferative capacity in vitro in the absence of the common exogenous cytokines and growth factor cocktails normally employed to stimulate cell expansion.